Acetamide,n-[4-(6-amino-4-methyl-2-pyridinyl)butyl]-

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: Acetamide,n-[4-(6-amino-4-methyl-2-pyridinyl)butyl]-
• 英文别名: N-[4-(6-amino-4-methylpyridin-2-yl)butyl]acetamide
• 化学式: C₁₂H₁₉N₃O
• 分子量: 221.3
• InChiKey: FEXXMCDOAAMAEM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  68
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  三乙胺 、 乙酸酐 、 2-amino-6-(4-aminobutyl)-4-methylpyridine 在 碳酸氢钠 、 氯化钠 、 乙酸乙酯 、 Sodium sulfate-III 、 silica gel 、 甲醇 、 二氯甲烷 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 48.0h， 以to give 27 mg (44% yield of 6-(4-acetamidobutyl)-2-amino-4-methylpyridine as an oil which的产率得到Acetamide,n-[4-(6-amino-4-methyl-2-pyridinyl)butyl]-
  参考文献：
  名称：

  Substituted 2-aminopyridines as inhibitors of nitric oxide synthase

  摘要：

  化合物公式为（I）的2-氨基吡啶衍生物及其药学上可接受的盐，在治疗一氧化氮合酶介导的疾病和紊乱方面已经被发现有用。##STR1##

  公开号：

  US05972975A1

文献信息

• US5972975A
  申请人：——

  公开号：US5972975A

  公开（公告）日：1999-10-26
• [EN] SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE<br/>[FR] 2-AMINOPYRIDINES SUBSTITUEES UTILISEES COMME INHIBITEURS DE SYNTHASE D'OXYDE D'AZOTE
  申请人：MERCK & CO., INC.

  公开号：WO1996018616A1

  公开（公告）日：1996-06-20

  (EN) Substituted 2-aminopyridine compounds and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders.(FR) Composés de 2-aminopyridine substituée et leurs sels viables sur le plan pharmaceutique pouvant être utilisés dans le traitement de maladies et de troubles dus à la synthase d'oxyde d'azote.
• [EN] SH3 PROTEIN DOMAINS AND THEIR LIGANDS<br/>[FR] DOMAINES PROTEINIQUES SH3 ET LEURS LIGANDS
  申请人：ADELAIDE RES & INNOVATION PTY

  公开号：WO2003013523A1

  公开（公告）日：2003-02-20

  The present invention relates generally to molecules capable of interaction with one or more domains within a proteinaceous molecule such as a peptide, polypeptide, protein or a macromolecule comprising a proteinaceous molecule. More particularly the present invention relates to molecules including ligands which are capable of interacting with, and more particularly, binding to, SH3 protein domains or homologs thereof and even more particularly to molecules including ligands which are capable of binding to SH3 domains having a three-dimensional ligand-binding site comprising a negatively charged residue and a hydrophobic residue linearly separated by at least five amino acid residues. The subject invention is preferably directed to the use of 2-aminopyridine, 2-aminoquinoline, 1-aminoisoquinoline and derivatives, homologs, analogs and mimetics thereof or pharmaceutically acceptable salts thereof which interact with SH3 domains, and more particularly to the binding of 2-aminopyridine, 2-aminoquinoline, 1-aminoisoquinoline and derivatives analogs and mimetics to SH3 domains as defined above. The present invention contemplates the use of a three dimensional structure of the subject SH3 domain to identify, screen and design amino-substituted and amino-substituted pyridines and aminoquinolines capable of binding to an SH3 domain. The present invention is also useful for the in silico selection of derivatives homologs, analogs and mimetics of 2-aminopyridine, 2-aminoquinoline, 1-aminoisoquinoline capable of binding to SH3 domains. The ligands of the present invention are useful in the development of a range of therapeutic and diagnostic agents.
• Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
  申请人：Merck & Co., Inc.

  公开号：US05972975A1

  公开（公告）日：1999-10-26

  Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. ##STR1##

  化合物公式为（I）的2-氨基吡啶衍生物及其药学上可接受的盐，在治疗一氧化氮合酶介导的疾病和紊乱方面已经被发现有用。##STR1##